A phase II trial to evaluate the combination of pixantrone and obinutuzumab for patients with relapsed aggressive lymphoma : final results of the prospective, multicentre GOAL trial

Hess, GeorgHüttmann, AndreasWitzens-Harig, MathiasDreyling, Martin H.Keller, UlrichMarks, ReinhardErnst, ThomasPott, ChristianeViardot, AndreasFrontzek, FabianTrautmann, MarcelRuckes, ChristianDeuster, OliverRosenwald, AndreasTheobald, MatthiasLenz, Goerg2023-01-192023-01-192022https://openscience.ub.uni-mainz.de/handle/20.500.12030/8620engCC-BY-NC-ND-4.0https://creativecommons.org/licenses/by-nc-nd/4.0/610 Medizin610 Medical sciencesA phase II trial to evaluate the combination of pixantrone and obinutuzumab for patients with relapsed aggressive lymphoma : final results of the prospective, multicentre GOAL trialZeitschriftenaufsatz